Latest news
ANIP: Q2 2026 revenue rose 25.9% to $266M, led by Rare Disease and Brands, with strong cash reserves - TradingViewTradingView · Fri, 07 Aug 2026 11:03:14 GMTANI Pharmaceuticals Reports Second-Quarter 2026 Results, Raises Cortrophin Gel Guidance and Reaffirms Full-Year Outlook - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 11:00:00 GMT